Life Science 2017 snapshots & 2018 ahead...

2017 was a strong growth year for life science venture capital fund raising and public company performance. New funds raised in 2017 include Flagship Pioneering ($618M) and Third Rock Ventures ($616M). In June, Atlas Ventures announced a new $350M fund for Biotech seed investment. Many of the top public Life Science Tool and Diagnostic companies had a great year on Wall Street. From the GenomeWeb index, winners included Exact Sciences (+293%), Foundation Medicine (+285%) and Myriad (+106%). Historically solid instrument companies soared too. Shares of Illumina grew 70%, Brucker 62%, Agilent 47% and Thermo 34%. Some of the losers included GenMark Diagnostics and NanoString Technologies

Categories
Follow Us
  • LinkedIn Social Icon
  • Twitter Basic Square
  • Facebook Social Icon

© 2020 The Sonder Group